Sequent Scientific Limited — Others, 08-08-2025: Shareholders meeting

Sequent Scientific announced that all nine proposed resolutions at its Fortieth Annual General Meeting were approved by shareholders. Key approvals include the adoption of financial statements for the year ended March 31, 2025, and the re-appointment of Mr. Rajaram Narayanan as Managing Director & CEO. Shareholders also approved remuneration for the MD & CEO, the payment of commission to Non-Executive Directors, and the re-appointment of Independent Directors Dr. Kamal Sharma and Mr. Milind Sarwate for second terms. The appointment of the Secretarial Auditor and ratification of the Cost Auditor's remuneration were also passed, ensuring continuity in governance and financial oversight.